A global pharmaceutical company faced challenges managing sensitive clinical and research data across siloed systems, leading to inefficiencies, compliance risks, and limited collaboration. By adopting a cloud-based data platform with AWS, Databricks, and Immuta, the organization centralized data while enforcing fine-grained access controls and automated governance. This enabled secure sharing of sensitive data such as PII and PHI across departments without compromising compliance with regulations like HIPAA. The solution reduced data duplication, improved collaboration, and accelerated analytics and machine learning initiatives. As a result, the company enhanced research efficiency, reduced operational costs, and enabled faster development of treatments and improved patient outcomes.

Join for free to read